Erfolgreiche Behandlung der chronischen myelomonozytären Leukämie mit VP 16-213
- 1 May 1979
- journal article
- case report
- Published by Springer Nature in Annals of Hematology
- Vol. 38 (5) , 421-424
- https://doi.org/10.1007/bf01007903
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- COMPARISON OF BIOLOGIC ACTIVITY OF VP-16-213 GIVEN IV AND ORALLY IN CAPSULES OR DRINK AMPULES1976
- SUBACUTE AND CHRONIC MYELOMONOCYTIC LEUKAEMIA: A DISTINCT HAEMATOLOGICAL ENTITYBritish Journal of Haematology, 1976
- Acute monoblastic leukemia: diagnosis and treatment of ten cases.1975
- Acute monoblastic leukemia: diagnosis and treatment of ten casesBlood, 1975
- Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomasCancer, 1974
- Chronic myelomonocytic leukemia in adults.1974
- Activity of a new glycosidic lignan derivative (VP 16-213) related to podophyllotoxin in experimental tumorsPublished by Elsevier ,1973
- The Significance of Lysozyme Estimations in Acute Myeloid and Chronic Monocytic LeukaemiaBritish Journal of Haematology, 1971
- Lysozymuria and renal tubular dysfunction in monocytic and myelomonocytic leukemiaThe American Journal of Medicine, 1969
- Monocytic leukemiaThe American Journal of Medicine, 1956